UBIFRANCE, the French agency for international business development, comes under the aegis of France’s Ministry for the Economy, Finance & Industry. With 65 Trade Commissions in 46 countries, UBIFRANCE accompanies French-based innovative companies and high-technology clusters in their international expansion.
• Technology partnering aimed at innovative businesses: UBIFRANCE accompanies innovative businesses to facilitate the joint development of processes, products and services, in collaboration with companies and R&D facilities based outside France.
• Innovative clusters’ partnering initiative: UBIFRANCE promotes collaborative projects on behalf of France’s high-tech clusters in order to foster technological co-operation within the innovation ecosystem worldwide.
Each year, the United States based UBIFRANCE HEATH TEAM works with more than 800 US and 300 cutting edge French Biotech-Pharma-Medtech companies including Big Pharma (such as Sanofi, Sanofi-Pasteur, Ipsen, Takeda, GSK, Merck, Abbott, Amgen, Pfizer, etc.), and small and medium size companies.
Our main recurring events are the French Biotech-Pharma-Medtech Tours, which provide US and French industry professionals with essential contacts and collaborative opportunities (licensing, R&D collaborations, commercial partnerships, etc.). Our goal is to accelerate the development of French companies in the US by providing advice, access to market information and business leads to our clients. These partnering events are free of charge for US-based companies thus providing French companies attending a huge number of opportunities with US companies’.